Takeshi Tsunoda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Takeshi Tsunoda has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Tohru Dairi
Graduate School of Engineering, Hokkaido University, N13 & W8, Kita-ku, Sapporo, Hokkaido 060-8628, Japan
8 shared publications - Yasushi Ogasawara
Graduate School of Engineering, Hokkaido University, Sapporo, Japan
8 shared publications - Taifo Mahmud
Department of Pharmaceutical Sciences, Oregon State University, Corvallis, USA
6 shared publications Chitose Maruyama
Department of Bioscience, Fukui Prefectural University, Fukui, Japan
3 shared publicationsSamuel Tanoeyadi
Department of Pharmaceutical Sciences, Oregon State University, Corvallis, Oregon 97331-3507 United States
3 shared publicationsYoshimitsu Hamano
Major in Bioscience and Biotechnology, Graduate School of Bioscience and Biotechnology, Fukui Prefectural University
3 shared publications
Latest Publications
- 7 September 2026
- Published by Springer Nature in Nature Catalysis
- Vol. 9 (10) , 1089-1098
Enzymatic skeletal editing reaction forming the 1,3,5-triazine core during biosynthesis of the anticancer nucleoside analogue 5-azacytidine
- 7 September 2026
- Published by Springer Nature in Nature Catalysis
- Vol. 9 (10) , 1089-1098
Enzymatic skeletal editing reaction forming the 1,3,5-triazine core during biosynthesis of the anticancer nucleoside analogue 5-azacytidine
- Open Access
- 5 January 2026
- Published by Wiley in ChemistryEurope
- Vol. 4 (1)
Functional Analysis of Three Dehydratase Domains, DH PKS , DH1 FabA , and DH2 FabA , in Microalgal Docosahexaenoic Acid Synthase
Schizochytrium sp., a eukaryotic microalga, biosynthesizes docosahexaenoic acid (DHA; C22:6 ω 3) by DHA synthase, which is composed of three subunits (OrfA to C) possessing multiple catalytic domains. The enzyme has three dehydratase (DH) domains, DH PKS in OrfA and tandem DH FabA (DH1 FabA and DH2 FabA ) domains in OrfC. In this study, the function of each of the DH domains was investigated by in vivo heterologous expression experiments in Escherichia coli and in vitro studies with recombinant truncated OrfA containing DH PKS and full‐length OrfC, in which one of the tandem DH FabA domains was inactivated by site‐directed mutagenesis, and acyl–acyl carrier protein (ACP) intermediates. Following heterologous expression, the DH1 FabA ‐ or DH2 FabA ‐inactivated enzyme produced no DHA, revealing that both domains are essential, while the DH PKS ‐inactivated enzyme showed significantly reduced DHA productivity, confirming that DH PKS is required for full production of DHA. Moreover, in vitro experiments showed that the C4‐ACP substrate was accepted by all of the DHs, but DH PKS and DH2 FabA showed higher activities than DH1 FabA . DH1 FabA catalyzed two types of reactions: (de)hydrations of C10‐, C16‐, and C22‐ACP substrates and (de)hydrations/2‐ trans to 2‐ cis isomerization of C8‐, C14‐, and C20‐ACP substrates. By contrast, DH2 FabA catalyzed (de)hydrations/2‐ trans to 3‐ cis isomerization of C6‐, C12‐, and C18‐ACP substrates.
- 5 January 2026
- Published by Wiley in ChemistryEurope
- Vol. 4 (1)
Open AccessFunctional Analysis of Three Dehydratase Domains, DH PKS , DH1 FabA , and DH2 FabA , in Microalgal Docosahexaenoic Acid Synthase
Schizochytrium sp., a eukaryotic microalga, biosynthesizes docosahexaenoic acid (DHA; C22:6 ω 3) by DHA synthase, which is composed of three subunits (OrfA to C) possessing multiple catalytic domains. The enzyme has three dehydratase (DH) domains, DH PKS in OrfA and tandem DH FabA (DH1 FabA and DH2 FabA ) domains in OrfC. In this study, the function of each of the DH domains was investigated by in vivo heterologous expression experiments in Escherichia coli and in vitro studies with recombinant truncated OrfA containing DH PKS and full‐length OrfC, in which one of the tandem DH FabA domains was inactivated by site‐directed mutagenesis, and acyl–acyl carrier protein (ACP) intermediates. Following heterologous expression, the DH1 FabA ‐ or DH2 FabA ‐inactivated enzyme produced no DHA, revealing that both domains are essential, while the DH PKS ‐inactivated enzyme showed significantly reduced DHA productivity, confirming that DH PKS is required for full production of DHA. Moreover, in vitro experiments showed that the C4‐ACP substrate was accepted by all of the DHs, but DH PKS and DH2 FabA showed higher activities than DH1 FabA . DH1 FabA catalyzed two types of reactions: (de)hydrations of C10‐, C16‐, and C22‐ACP substrates and (de)hydrations/2‐ trans to 2‐ cis isomerization of C8‐, C14‐, and C20‐ACP substrates. By contrast, DH2 FabA catalyzed (de)hydrations/2‐ trans to 3‐ cis isomerization of C6‐, C12‐, and C18‐ACP substrates.
- 2 April 2025
- Published by Oxford University Press (OUP) in Bioscience, Biotechnology, and Biochemistry
- Vol. 89 (7) , 985-989
Identification of peptaibols as specific inhibitors of the futalosine pathway
Menaquinone is an indispensable cofactor in the electron-transfer pathway for most Gram-positive bacteria. While most bacteria biosynthesize menaquinone by the well-known canonical pathway, some bacteria including Helicobacter pylori, which is a pathogen causing stomach cancer, use the futalosine pathway. Because beneficial intestinal bacteria such as lactobacilli use the canonical pathway, the futalosine pathway will be a great target for developing antibiotics specific to H. pylori. In this study, we searched for such metabolites from actinomycetes and fungi and identified 4 new peptaibols from culture broth of Verruciconidia sp. FKI-8918 as specific inhibitors of the futalosine pathway.
- 2 April 2025
- Published by Oxford University Press (OUP) in Bioscience, Biotechnology, and Biochemistry
- Vol. 89 (7) , 985-989
Identification of peptaibols as specific inhibitors of the futalosine pathway
Menaquinone is an indispensable cofactor in the electron-transfer pathway for most Gram-positive bacteria. While most bacteria biosynthesize menaquinone by the well-known canonical pathway, some bacteria including Helicobacter pylori, which is a pathogen causing stomach cancer, use the futalosine pathway. Because beneficial intestinal bacteria such as lactobacilli use the canonical pathway, the futalosine pathway will be a great target for developing antibiotics specific to H. pylori. In this study, we searched for such metabolites from actinomycetes and fungi and identified 4 new peptaibols from culture broth of Verruciconidia sp. FKI-8918 as specific inhibitors of the futalosine pathway.
- Open Access
- 21 March 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (12)
Substrate specificities of two ketosynthases in eukaryotic microalgal and prokaryotic marine bacterial DHA synthases
Highly reducing iterative polyketide synthases (HR-iPKSs) are huge enzyme complexes with multiple catalytic domains that biosynthesize polyketides by intrinsically programmed iterative carbon chain extensions and reductions. Unlike most HR-iPKSs, which possess a single ketosynthase (KS) domain for all carbon chain elongations, polyunsaturated fatty acid (PUFA) synthases contain two KS domains. We previously examined the substrate specificities of two KS domains of prokaryotic marine PUFA synthases with several acyl-ACP intermediates and showed that the two KS domains are utilized differentially depending on the carbon chain length. In this study, we investigated two KS domains in a eukaryotic microalgal DHA synthase, KS A and KS B , which show low similarities to those of prokaryotic marine enzymes, together with almost all the acyl-ACP intermediates. C6-, C12-, and C18-ACPs were exclusively accepted by KS A while KS B utilized C-8. C14- and C20-ACPs. In contrast, both KS A and KS B showed activities against C2-, C4-, and C10-ACPs. A general tendency was observed in which both the prokaryotic KS and the eukaryotic KS recognized the acyl structures in the vicinity of the thioester in ACP substrates except for short-chain substrates.
- 21 March 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (12)
Open AccessSubstrate specificities of two ketosynthases in eukaryotic microalgal and prokaryotic marine bacterial DHA synthases
Highly reducing iterative polyketide synthases (HR-iPKSs) are huge enzyme complexes with multiple catalytic domains that biosynthesize polyketides by intrinsically programmed iterative carbon chain extensions and reductions. Unlike most HR-iPKSs, which possess a single ketosynthase (KS) domain for all carbon chain elongations, polyunsaturated fatty acid (PUFA) synthases contain two KS domains. We previously examined the substrate specificities of two KS domains of prokaryotic marine PUFA synthases with several acyl-ACP intermediates and showed that the two KS domains are utilized differentially depending on the carbon chain length. In this study, we investigated two KS domains in a eukaryotic microalgal DHA synthase, KS A and KS B , which show low similarities to those of prokaryotic marine enzymes, together with almost all the acyl-ACP intermediates. C6-, C12-, and C18-ACPs were exclusively accepted by KS A while KS B utilized C-8. C14- and C20-ACPs. In contrast, both KS A and KS B showed activities against C2-, C4-, and C10-ACPs. A general tendency was observed in which both the prokaryotic KS and the eukaryotic KS recognized the acyl structures in the vicinity of the thioester in ACP substrates except for short-chain substrates.
- Open Access
- 13 January 2025
- Published by Springer Nature in Communications Chemistry
- Vol. 8 (1) , 1-8
Biosynthesis of lactacystin as a proteasome inhibitor
Lactacystin is an irreversible proteasome inhibitor isolated from Streptomyces lactacystinicus. Despite its importance for its biological activity, the biosynthesis of lactacystin remains unknown. In this study, we identified the lactacystin biosynthetic gene cluster by gene disruption and heterologous expression experiments. We also examined the functions of the genes encoding a PKS/NRPS hybrid protein (LctA), NRPS (LctB), ketosynthase-like cyclase (LctC), cytochrome P450 (LctD), MbtH-like protein (LctE), and formyltransferase (LctF) by in vivo and in vitro experiments. In particular, we demonstrated that LctF directly transferred the formyl group of 10-N-formyl tetrahydrofolate to CoA. The formyl group of formyl-CoA was then transferred to ACP1 by LctA_AT1 to form formyl-ACP1. This is the first example of an AT domain recognizing a formyl group. The formyl group is perhaps transferred to methylmalonate tethered on LctA_ACP2 to yield methylmalonyl-semialdehyde-ACP2. Then, it would be condensed with leucine bound to PCP in LctB by the C domain in LctA. Using a mimic compound, we confirmed that LctC catalyzed the formation of the cyclic α,α-disubstituted amino acid structure with concomitant release of the product from PCP. Thus, we figured out the overall biosynthesis of lactacystin including a novel role of a formyl group in a secondary metabolite.
- 13 January 2025
- Published by Springer Nature in Communications Chemistry
- Vol. 8 (1) , 1-8
Open AccessBiosynthesis of lactacystin as a proteasome inhibitor
Lactacystin is an irreversible proteasome inhibitor isolated from Streptomyces lactacystinicus. Despite its importance for its biological activity, the biosynthesis of lactacystin remains unknown. In this study, we identified the lactacystin biosynthetic gene cluster by gene disruption and heterologous expression experiments. We also examined the functions of the genes encoding a PKS/NRPS hybrid protein (LctA), NRPS (LctB), ketosynthase-like cyclase (LctC), cytochrome P450 (LctD), MbtH-like protein (LctE), and formyltransferase (LctF) by in vivo and in vitro experiments. In particular, we demonstrated that LctF directly transferred the formyl group of 10-N-formyl tetrahydrofolate to CoA. The formyl group of formyl-CoA was then transferred to ACP1 by LctA_AT1 to form formyl-ACP1. This is the first example of an AT domain recognizing a formyl group. The formyl group is perhaps transferred to methylmalonate tethered on LctA_ACP2 to yield methylmalonyl-semialdehyde-ACP2. Then, it would be condensed with leucine bound to PCP in LctB by the C domain in LctA. Using a mimic compound, we confirmed that LctC catalyzed the formation of the cyclic α,α-disubstituted amino acid structure with concomitant release of the product from PCP. Thus, we figured out the overall biosynthesis of lactacystin including a novel role of a formyl group in a secondary metabolite.
- 15 October 2024
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 19 (11) , 2277-2283
2-Deoxy-4-epi-scyllo-inosose (DEI) is the Product of EboD, a Highly Conserved Dehydroquinate Synthase-like Enzyme in Bacteria and Eustigmatophyte Algae
A cryptic cluster of genes, known as the ebo cluster, has been found in a variety of genomic contexts among bacteria and algae. In Pseudomonas fluorescens NZI7, the ebo cluster (a.k.a. EDB cluster) is involved in the bacterial repellent mechanism against nematode grazing. In cyanobacteria, the cluster plays a role in the transport of the scytonemin monomer from the cytosol to the periplasm. Despite their broad distribution and interesting phenotypes, neither the pathway nor the functions of the enzymes are known. Here we show that EboD proteins from the ebo clusters in Nostoc punctiforme and Sporocytophaga myxococcoides catalyze the cyclization of mannose 6-phosphate to a novel cyclitol, 2-deoxy-4-epi-scyllo-inosose. The enzyme product is postulated to be a precursor of a signaling molecule or a transporter in the organisms. This study sheds the first light onto ebo/EDB pathways and established a functionally distinct enzyme that extends the diversity of sugar phosphate cyclases.
- 15 October 2024
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 19 (11) , 2277-2283
2-Deoxy-4-epi-scyllo-inosose (DEI) is the Product of EboD, a Highly Conserved Dehydroquinate Synthase-like Enzyme in Bacteria and Eustigmatophyte Algae
A cryptic cluster of genes, known as the ebo cluster, has been found in a variety of genomic contexts among bacteria and algae. In Pseudomonas fluorescens NZI7, the ebo cluster (a.k.a. EDB cluster) is involved in the bacterial repellent mechanism against nematode grazing. In cyanobacteria, the cluster plays a role in the transport of the scytonemin monomer from the cytosol to the periplasm. Despite their broad distribution and interesting phenotypes, neither the pathway nor the functions of the enzymes are known. Here we show that EboD proteins from the ebo clusters in Nostoc punctiforme and Sporocytophaga myxococcoides catalyze the cyclization of mannose 6-phosphate to a novel cyclitol, 2-deoxy-4-epi-scyllo-inosose. The enzyme product is postulated to be a precursor of a signaling molecule or a transporter in the organisms. This study sheds the first light onto ebo/EDB pathways and established a functionally distinct enzyme that extends the diversity of sugar phosphate cyclases.
- 30 April 2024
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 63 (10) , 1359-1368
Synthesis of the Carba-Analogs of the α-Pyranose and β-Pyranose Forms of Sedoheptulose 7-Phosphate and Probing the Stereospecificity of Sedoheptulose 7-Phosphate Cyclases
Sedoheptulose 7-phosphate (SH7P) cyclases are a subset of sugar phosphate cyclases that are known to catalyze the first committed step in many biosynthetic pathways in primary and secondary metabolism. Among them are 2-epi-5-epi-valiolone synthase (EEVS) and 2-epi-valiolone synthase (EVS), two closely related SH7P cyclases that catalyze the conversion of SH7P to 2-epi-5-epi-valiolone and 2-epi-valiolone, respectively. However, how these two homologous enzymes use a common substrate to produce stereochemically different products is unknown. Two competing hypotheses have been proposed for the stereospecificity of EEVS and EVS: (1) variation in aldol acceptor geometry during enzyme catalysis, and (2) preselection of the alpha-pyranose or beta-pyranose forms of the substrate by the enzymes. Yet, there is no direct evidence to support or rule out either of these hypotheses. Here we report the synthesis of the carba-analogs of the alpha-pyranose and beta-pyranose forms of SH7P and their use in probing the stereospecificity of ValA (EEVS from Streptomyces hygroscopicus subsp. jinggangensis) and Amir_2000 (EVS from Actinosynnema mirum DSM 43827). Kinetic studies of the enzymes in the presence of the synthetic compounds as well as docking studies of the enzymes with the alpha- and beta-pyranose forms of SH7P suggest that the inverted configuration of the products of EEVS and EVS is not due to the preselection of the different forms of the substrate by the enzymes.
- 30 April 2024
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 63 (10) , 1359-1368
Synthesis of the Carba-Analogs of the α-Pyranose and β-Pyranose Forms of Sedoheptulose 7-Phosphate and Probing the Stereospecificity of Sedoheptulose 7-Phosphate Cyclases
Sedoheptulose 7-phosphate (SH7P) cyclases are a subset of sugar phosphate cyclases that are known to catalyze the first committed step in many biosynthetic pathways in primary and secondary metabolism. Among them are 2-epi-5-epi-valiolone synthase (EEVS) and 2-epi-valiolone synthase (EVS), two closely related SH7P cyclases that catalyze the conversion of SH7P to 2-epi-5-epi-valiolone and 2-epi-valiolone, respectively. However, how these two homologous enzymes use a common substrate to produce stereochemically different products is unknown. Two competing hypotheses have been proposed for the stereospecificity of EEVS and EVS: (1) variation in aldol acceptor geometry during enzyme catalysis, and (2) preselection of the alpha-pyranose or beta-pyranose forms of the substrate by the enzymes. Yet, there is no direct evidence to support or rule out either of these hypotheses. Here we report the synthesis of the carba-analogs of the alpha-pyranose and beta-pyranose forms of SH7P and their use in probing the stereospecificity of ValA (EEVS from Streptomyces hygroscopicus subsp. jinggangensis) and Amir_2000 (EVS from Actinosynnema mirum DSM 43827). Kinetic studies of the enzymes in the presence of the synthetic compounds as well as docking studies of the enzymes with the alpha- and beta-pyranose forms of SH7P suggest that the inverted configuration of the products of EEVS and EVS is not due to the preselection of the different forms of the substrate by the enzymes.
- 10 January 2024
- Published by Springer Nature in The Journal of Antibiotics
- Vol. 77 (3) , 182-184
Identification of a new oligomycin derivative as a specific inhibitor of the alternative peptidoglycan biosynthetic pathway
Peptidoglycan is an important macromolecule in bacterial cell walls to maintain cell integrity, and its biosynthetic pathway has been well studied. Recently, we demonstrated that some bacteria such as Xanthomonas oryzae, a pathogen causing bacterial blight of rice, used an alternative pathway for peptidoglycan biosynthesis. In this pathway, MurD2, a MurD homolog, catalyzed the attachment of l-Glu to UDP-MurNAc-l-Ala and MurL, which did not show homology to any known protein, catalyzed epimerization of the terminal l-Glu of the MurD2 product to generate UDP-MurNAc-l-Ala-d-Glu. Because the alternative pathway also operates in some other plant pathogens and opportunistic pathogens, specific inhibitors of the alternative pathway could function as pesticides and antibiotics for these pathogens. In this study, we searched for specific inhibitors of the alternative pathway from metabolites produced by actinomycetes and identified a new oligomycin-class polyketide, which was revealed to inhibit the MurD2 reaction, in culture broth of Micromonospora sp. K18-0097.
- 10 January 2024
- Published by Springer Nature in The Journal of Antibiotics
- Vol. 77 (3) , 182-184
Identification of a new oligomycin derivative as a specific inhibitor of the alternative peptidoglycan biosynthetic pathway
Peptidoglycan is an important macromolecule in bacterial cell walls to maintain cell integrity, and its biosynthetic pathway has been well studied. Recently, we demonstrated that some bacteria such as Xanthomonas oryzae, a pathogen causing bacterial blight of rice, used an alternative pathway for peptidoglycan biosynthesis. In this pathway, MurD2, a MurD homolog, catalyzed the attachment of l-Glu to UDP-MurNAc-l-Ala and MurL, which did not show homology to any known protein, catalyzed epimerization of the terminal l-Glu of the MurD2 product to generate UDP-MurNAc-l-Ala-d-Glu. Because the alternative pathway also operates in some other plant pathogens and opportunistic pathogens, specific inhibitors of the alternative pathway could function as pesticides and antibiotics for these pathogens. In this study, we searched for specific inhibitors of the alternative pathway from metabolites produced by actinomycetes and identified a new oligomycin-class polyketide, which was revealed to inhibit the MurD2 reaction, in culture broth of Micromonospora sp. K18-0097.
- 14 December 2023
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 25 (1) , 349-354
Peptide Epimerase Responsible for d-Amino Acid Introduction in Poly-γ-glutamic Acid Biosynthesis
Poly-gamma-glutamic acid (PGA) is a natural polymer of d- and/or l-glutamic acid (Glu) linked by isopeptide bonds. We recently showed that PGA synthetase, an enzyme complex composed of PgsB, PgsC, and PgsA, uses only l-Glu for polymerization, and d-Glu residues are introduced by peptide epimerization. However, it remains unclear which of the three enzymes is responsible for epimerization because in vitro functional characterization of the membrane-associated PgsBCA complex has never been successful. Here, we performed gene exchange experiments and showed that PgsA is responsible for the epimerization. Additionally, we identified a region in PgsA that modulates epimerization activity based on homology modeling from the recently solved structure of MslH, which showed 53% identity to PgsA. Our results suggested that d/l-ratios of the PGA product can be altered by introducing amino acid substitutions in this region, which will be useful for the production of PGA with controlled d/l-ratios.
- 14 December 2023
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 25 (1) , 349-354
Peptide Epimerase Responsible for d-Amino Acid Introduction in Poly-γ-glutamic Acid Biosynthesis
Poly-gamma-glutamic acid (PGA) is a natural polymer of d- and/or l-glutamic acid (Glu) linked by isopeptide bonds. We recently showed that PGA synthetase, an enzyme complex composed of PgsB, PgsC, and PgsA, uses only l-Glu for polymerization, and d-Glu residues are introduced by peptide epimerization. However, it remains unclear which of the three enzymes is responsible for epimerization because in vitro functional characterization of the membrane-associated PgsBCA complex has never been successful. Here, we performed gene exchange experiments and showed that PgsA is responsible for the epimerization. Additionally, we identified a region in PgsA that modulates epimerization activity based on homology modeling from the recently solved structure of MslH, which showed 53% identity to PgsA. Our results suggested that d/l-ratios of the PGA product can be altered by introducing amino acid substitutions in this region, which will be useful for the production of PGA with controlled d/l-ratios.
- 4 August 2023
- Published by Oxford University Press (OUP) in Bioscience, Biotechnology, and Biochemistry
- Vol. 87 (11) , 1316-1322
Peptide epimerase-dehydratase complex responsible for biosynthesis of the linaridin class ribosomal peptides
Grisemycin, salinipeptin, and cypemycin belong to the linaridin class of ribosomally synthesized and posttranslationally modified peptides that contain multiple dehydrobutyrine and D-amino acid residues. The biosynthetic gene clusters of these linaridins lack obvious candidate genes for the dehydratase and epimerase required to introduce dehydrobutyrine and D-amino acid residues, respectively. However, we previously demonstrated that the grisemycin (grm) cluster contained cryptic dehydratase and epimerase genes by heterologous expression of this biosynthetic gene cluster in Streptomyces lividans and proposed that two genes (grmH and grmL) with unknown functions catalyze dehydration and epimerization reactions. In this study, we confirmed that both GrmH and GrmL, which were shown to constitute a protein complex by a co-purification experiment, were required to catalyze the dehydration, epimerization, and proteolytic cleavage of a precursor peptide GrmA by in vivo experiments. Furthermore, we demonstrated that GrmH/GrmL complex accepted salinipeptin and cypemycin precursor peptides, which possess three additional amino acids.
- 4 August 2023
- Published by Oxford University Press (OUP) in Bioscience, Biotechnology, and Biochemistry
- Vol. 87 (11) , 1316-1322
Peptide epimerase-dehydratase complex responsible for biosynthesis of the linaridin class ribosomal peptides
Grisemycin, salinipeptin, and cypemycin belong to the linaridin class of ribosomally synthesized and posttranslationally modified peptides that contain multiple dehydrobutyrine and D-amino acid residues. The biosynthetic gene clusters of these linaridins lack obvious candidate genes for the dehydratase and epimerase required to introduce dehydrobutyrine and D-amino acid residues, respectively. However, we previously demonstrated that the grisemycin (grm) cluster contained cryptic dehydratase and epimerase genes by heterologous expression of this biosynthetic gene cluster in Streptomyces lividans and proposed that two genes (grmH and grmL) with unknown functions catalyze dehydration and epimerization reactions. In this study, we confirmed that both GrmH and GrmL, which were shown to constitute a protein complex by a co-purification experiment, were required to catalyze the dehydration, epimerization, and proteolytic cleavage of a precursor peptide GrmA by in vivo experiments. Furthermore, we demonstrated that GrmH/GrmL complex accepted salinipeptin and cypemycin precursor peptides, which possess three additional amino acids.